From: Network pharmacology and molecular docking analysis on Shenfu Qiangxin indicate mTOR is a potential target to treat heart failure
Compound name
Molecular docking binding energy
Moracin D
− 8.3
Cerevisterol
− 7.5
(22e,24r)-Ergosta-6-en-3beta,5alpha,6beta-triol
− 7.2
Deoxyandrographolide
− 7.0
Moracin O
Polyporusterone E
− 8.7